Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 5 Similar Profiles
Neoplasms Medicine & Life Sciences
Neurilemmoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neurofibromatosis 1 Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Brain Neoplasms Medicine & Life Sciences
Central Nervous System Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2007 2022

Central Nervous System Neoplasms
Induction Chemotherapy
Optic Nerve Glioma
Neurofibromatosis 1

Research Output 1990 2018

Predictive Value and Interrater Reliability of Radiographic Factors in Neurofibromatosis Patients With Dystrophic Scoliosis

Larson, A. N., Ledonio, C. G. T., Brearley, A. M., Sucato, D. J., Carreon, L. Y., Crawford, A. H., Stevenson, D. A., Vitale, M. G., Moertel, C. L. & Polly, D. W. Jan 1 2018 (Accepted/In press) In : Spine Deformity.

Research output: Contribution to journalArticle

Neurofibromatosis 1

An Unusual Pelvic Mass in a Pediatric Patient: A Case Report and Review of the Pathology

Bauman, B. D., Moertel, C. L., Zheng, E., Louiselle, A., Berdan, E., Berger, D. & Segura, B. Jan 1 2017 In : Journal of Pediatric Hematology/Oncology. 39, 4, p. 306-308 3 p.

Research output: Contribution to journalReview article

Neurofibromatosis 1
Gastrointestinal Stromal Tumors
Meckel Diverticulum
Extracellular Signal-Regulated MAP Kinases
Mitogen-Activated Protein Kinases
Acneiform Eruptions

Neonatal Respiratory Failure Caused by Congenital Diffuse Intrinsic Pontine Glioma

Satrom, K. M., Phelan, R. A., Moertel, C. L., Brent Clark, H., Johnson, D. E. & George, T. N. May 1 2017 In : Journal of child neurology. 32, 6, p. 533-536 4 p.

Research output: Contribution to journalArticle

Respiratory Insufficiency
Respiratory Sounds
Palliative Care
4 Citations

Phase I trial of low-dose interleukin 2 therapy in patients with Wiskott-Aldrich syndrome

Jyonouchi, S., Gwafila, B., Gwalani, L. A., Ahmad, M., Moertel, C., Holbert, C., Kim, J. Y., Kobrinsky, N., Roy-Ghanta, S. & Orange, J. S. Jun 1 2017 In : Clinical Immunology. 179, p. 47-53 7 p.

Research output: Contribution to journalArticle

Wiskott-Aldrich Syndrome
Natural Killer Cells